BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 21616691)

  • 1. Active surveillance vs. treatment for low-risk prostate cancer: a cost comparison.
    Eldefrawy A; Katkoori D; Abramowitz M; Soloway MS; Manoharan M
    Urol Oncol; 2013 Jul; 31(5):576-80. PubMed ID: 21616691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilizing time-driven activity-based costing to understand the short- and long-term costs of treating localized, low-risk prostate cancer.
    Laviana AA; Ilg AM; Veruttipong D; Tan HJ; Burke MA; Niedzwiecki DR; Kupelian PA; King CR; Steinberg ML; Kundavaram CR; Kamrava M; Kaplan AL; Moriarity AK; Hsu W; Margolis DJ; Hu JC; Saigal CS
    Cancer; 2016 Feb; 122(3):447-55. PubMed ID: 26524087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost comparison of robotic, laparoscopic, and open radical prostatectomy for prostate cancer.
    Bolenz C; Gupta A; Hotze T; Ho R; Cadeddu JA; Roehrborn CG; Lotan Y
    Eur Urol; 2010 Mar; 57(3):453-8. PubMed ID: 19931979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hospitalization costs for radical prostatectomy attributable to robotic surgery.
    Kim SP; Shah ND; Karnes RJ; Weight CJ; Shippee ND; Han LC; Boorjian SA; Smaldone MC; Frank I; Gettman MT; Tollefson MK; Thompson RH
    Eur Urol; 2013 Jul; 64(1):11-6. PubMed ID: 22959352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative hospital cost-analysis of open and robotic-assisted radical prostatectomy.
    Tomaszewski JJ; Matchett JC; Davies BJ; Jackman SV; Hrebinko RL; Nelson JB
    Urology; 2012 Jul; 80(1):126-9. PubMed ID: 22608294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of urologist reimbursement for managing patients with low-risk prostate cancer by active surveillance versus total prostatectomy.
    Manoharan M; Eldefrawy A; Katkoori D; Antebi E; Soloway MS
    Prostate Cancer Prostatic Dis; 2010 Dec; 13(4):307-10. PubMed ID: 20838414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How does robot-assisted radical prostatectomy (RARP) compare with open surgery in men with high-risk prostate cancer?
    Punnen S; Meng MV; Cooperberg MR; Greene KL; Cowan JE; Carroll PR
    BJU Int; 2013 Aug; 112(4):E314-20. PubMed ID: 23451984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary cancers after intensity-modulated radiotherapy, brachytherapy and radical prostatectomy for the treatment of prostate cancer: incidence and cause-specific survival outcomes according to the initial treatment intervention.
    Zelefsky MJ; Pei X; Teslova T; Kuk D; Magsanoc JM; Kollmeier M; Cox B; Zhang Z
    BJU Int; 2012 Dec; 110(11):1696-701. PubMed ID: 22889401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Financial comparative analysis of minimally invasive surgery to open surgery for localized prostate cancer: a single-institution experience.
    Mouraviev V; Nosnik I; Sun L; Robertson CN; Walther P; Albala D; Moul JW; Polascik TJ
    Urology; 2007 Feb; 69(2):311-4. PubMed ID: 17320670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-Effectiveness of Active Surveillance, Radical Prostatectomy and External Beam Radiotherapy for Localized Prostate Cancer: An Analysis of the ProtecT Trial.
    Sharma V; Wymer KM; Borah BJ; Barocas DA; Thompson RH; Karnes RJ; Boorjian SA
    J Urol; 2019 Nov; 202(5):964-972. PubMed ID: 31112105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
    Vargas C; Kestin LL; Weed DW; Krauss D; Vicini FA; Martinez AA
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):714-24. PubMed ID: 15708249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local cost structures and the economics of robot assisted radical prostatectomy.
    Scales CD; Jones PJ; Eisenstein EL; Preminger GM; Albala DM
    J Urol; 2005 Dec; 174(6):2323-9. PubMed ID: 16280833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the introduction of a robotic training programme on prostate cancer stage migration at a single tertiary referral centre.
    Briganti A; Bianchi M; Sun M; Suardi N; Gallina A; Abdollah F; Bertini R; Colombo R; Girolamo VD; Salonia A; Scattoni V; Karakiewicz PI; Guazzoni G; Rigatti P; Montorsi F
    BJU Int; 2013 Jun; 111(8):1222-30. PubMed ID: 23145532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost comparison of radical retropubic and radical perineal prostatectomy: single institution experience.
    Silverstein AD; Weizer AZ; Dowell JM; Auge BK; Paulson DF; Dahm P
    Urology; 2004 Apr; 63(4):746-50. PubMed ID: 15072893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radical prostatectomy versus external-beam radiotherapy for localized prostate cancer: long-term effect on biochemical control-in search of the optimal treatment.
    González-San Segundo C; Herranz-Amo F; Alvarez-González A; Cuesta-Álvaro P; Gómez-Espi M; Paños-Fagundo E; Santos-Miranda JA
    Ann Surg Oncol; 2011 Oct; 18(10):2980-7. PubMed ID: 21431406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radical prostatectomy for prostatic adenocarcinoma: a matched comparison of open retropubic and robot-assisted techniques.
    Krambeck AE; DiMarco DS; Rangel LJ; Bergstralh EJ; Myers RP; Blute ML; Gettman MT
    BJU Int; 2009 Feb; 103(4):448-53. PubMed ID: 18778350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radical prostatectomy vs radiation therapy and androgen-suppression therapy in high-risk prostate cancer.
    Westover K; Chen MH; Moul J; Robertson C; Polascik T; Dosoretz D; Katin M; Salenius S; D'Amico AV
    BJU Int; 2012 Oct; 110(8):1116-21. PubMed ID: 22540922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A nationwide charge comparison of the principal treatments for early stage prostate carcinoma.
    Brandeis J; Pashos CL; Henning JM; Litwin MS
    Cancer; 2000 Oct; 89(8):1792-9. PubMed ID: 11042575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost comparison between watchful waiting with active surveillance and active treatment of clinically localized prostate cancer.
    Corcoran AT; Peele PB; Benoit RM
    Urology; 2010 Sep; 76(3):703-7. PubMed ID: 20381846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
    Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.